artco-shutterstock-com
Artco / Shutterstock.com
27 September 2016Americas

Glenmark partners with Particle Sciences in Abraxane generic deal

India-based pharmaceutical company Glenmark has signed a wide-ranging drug agreement with Particle Sciences, a provider of drug development services.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
31 January 2018   Biopharmaceutical company Celgene has reached an agreement with Actavis that will terminate pending patent litigation over Abraxane.